A proposed reference method for plasminogen activators that enables calculation of enzyme activities in SI units

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 8, 2004, Pages 1416-1421

  Longstaff, Colin ^a   Whitton, C M ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Plasminogen activation; Thrombolysis

Indexed keywords

CHROMOGENIC SUBSTRATE; FIBRIN; FIBRINOGEN; PLASMIN; RETEPLASE; STAPHYLOKINASE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ACCURACY; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HEART INFARCTION; IN VIVO STUDY; INTERNATIONAL COOPERATION; INTERNATIONAL STANDARD UNIT; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

FIBRIN; FIBRINOGEN; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; HUMANS; INTERNATIONAL SYSTEM OF UNITS; KINETICS; LABORATORIES; MODELS, CHEMICAL; MYOCARDIAL INFARCTION; PLASMIN; PLASMINOGEN ACTIVATORS; RECEPTORS, CELL SURFACE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; STREPTOKINASE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 4544232604     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00816.x     Document Type: Article

References (35)

1. Gram J, Kluft K, Barrowcliffe T, Declerk P, Francis CW, Gaffney P, Jesperson J. PGM guidelines for description of criteria and methods for testing of specificity of assay methods for quantities in the fibrinolytic system. In: http://www.Ifcc.Org/Ejifcc/Vol12no2/Pgmguidelines.htm 2000.
2. Gram J, Kluft C, Jespersen J. Standardisation of measurment of components of the fibrinolytic system-introduction and current status. http://www.ifcc.org/ejifcc/vol2no2/standcompfibsys.htm 2000.
3. Jackson CM, White GC, 2nd Barrowcliffe T, Esnouf MP, Jespersen J, Kluft C, Lenahan J. A reference system approach to future standardization of laboratory tests for hemostasis: a position paper of the Joint Committee of the IFCC Scientific Division and the ISTH Scientific and Standardization Committee. Thromb Haemost 2002; 87: 165-9.
4. Sands D, Whitton C, Merton R, Longstaff C. A collaborative study to establish the 3rd international standard for tissue plasminogen activator. Thromb Haemost 2002; 88: 294-7.
5. Sands D, Whitton C, Longstaff C. An international collaborative study to establish the 3rd International Standard for Streptokinase. J Thromb Haemost 2004; 2: 1411-15.
6. Kuzmic P. Program DYNAFIT for the analysis of enzyme kinetic data: application to HIV proteinase. Anal Biochem 1996; 237: 260-73.
7. Cornish-Bowden A. In: Fundamentals of Enzyme Kinetics. London: Portland Press Ltd, 1996, 112-5.
8. Longstaff C, Gaffney PJ. Serpin-serine protease binding kinetics: alpha 2-antiplasmin as a model inhibitor. Biochemistry 1991; 30: 979-86.
9. Leatherbarrow RJ. Grafit, Version 4.0. Staines, UK: Erithacus Software, Ltd, 1998.
10. Ranby M. Studies on the kinetics of plasminogen activation by tissue plasminogen activator. Biochim Biophys Acta 1982; 704: 461-9.
11. Chibber BA, Morris JP, Castellino FJ. Effects of human fibrinogen and its cleavage products on activation of human plasminogen by streptokinase. Biochemistry 1985; 24: 3429-34.
12. Carlson RH, Garnick RL, Jones AJ, Meunier AM. The determination of recombinant human tissue-type plasminogen activator activity by turbidimetry using a microcentrifugal analyzer. Anal Biochem 1988; 168: 428-35.
13. Longstaff C, Clough AM, Gaffney PJ. Kinetics of plasmin activation of single chain urinary-type plasminogen activator (scu-PA) and demonstration of a high affinity interaction between scu-PA and plasminogen. J Biol Chem 1992; 267: 173-9.
14. Kohnert U, Horsch B, Fischer S. A variant of tissue plasminogen activator (t-PA) comprised of kringle 2 and the protease domain shows a significant difference in the in vitro rate of plasmin formation as compared to the recombinant human t-PA from transformed chinese hamster ovary cells. Fibrinolysis 1993; 7: 365-72.
15. Rijken DC, Jie AF. Interaction of reteplase with heparin. A comparison between reteplase and alteplase. Blood Coagul Fibrinolysis 1996; 7: 561-6.
16. Lenich C, Pannell R, Henkin J, Gurewich V. The influence of glycosylation on the catalytic and fibrinolytic properties of pro-urokinase. Thromb Haemost 1992; 68: 539-44.
17. Plough J, Kjeldgaard N. Urokinase, an activator of plasminogen from human urine. 1. Isolation and properties. Biochim Biophys Acta 1957; 24: 278-82.
18. Lassen M. The estimation of fibrinolytic components by means of the lysis time method. Scand J Clin Laboratory Invest 1958; 10: 384-9.
19. Astrup, J, Mullertz S. The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys 1952; 40: 346-51.
20. Sidelmann J, Jespersen J, Gram J. Plasminogen activator activity and plasma-coagulum lysis measured by use of optimized fibrin gel structure preformed in microtiter plates. Clin Chem 1995; 41 979-85.
21. Beebe DP, Aronson DL. An automated fibrinolytic assay performed in microtiter plates. Thromb Res 1987; 47: 123-8.
22. Jones AJ, Meunier AM. A precise and rapid microtitre plate clot lysis assay: methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis. Thromb Haemost 1990; 64: 455-63.
23. Lewis ML, Nachtwey DS, Damron KL. A miniaturized fibrinolytic assay for plasminogen activators. Thromb Res 1991; 64: 223-34.
24. Swank PR, Lewis ML, Damron KL. A computer program for microplate reader interface and analysis of kinetic, microclot lysis assays. Thromb Res 1991; 64: 235-42.
25. Samama M, Castel M, Matsuo O, Hoylaerts M, Lijnen HR. Comparative study of the activity of high and low molecular weight urokinase in the presence of fibrin. Thromb Haemost 1982; 47: 36-40.
26. Hoylaerts M, Rijken DC, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem 1982; 257: 2912-9.
27. Triscott MX, Bottoms JD, Beard GA, Doellgast GJ. Enzyme linked fibrinolytic assay (ELFA): a new method for the measurement of t-PA in plasma using enzyme labelled fibrin. Thromb Res 1990; 59 723-33.
28. Angles-Cano E. A spectrophotometric solid-phase fibrin-tissue plasminogen activator activity assay (SOFIA-tPA) for high-fibrin-affinity tissue plasminogen activators [published erratum appears in Anal Biochem 1986 August 1; 156(2): 524]. Anal Biochem 1986; 153: 201-10.
29. Bennett WF, Paoni NF, Keyt BA, Botstein D, Jones AJ, Presta L, Wurm FM, Zoller MJ. High resolution analysis of functional determinants on human tissue-type plasminogen activator. J Biol Chem 1991; 266: 5191-201.
30. Verheijen JH, Mullaart E, Chang GT, Kluft C, Wijngaards G. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemost 1982; 48: 266-9.
31. Johnson A, Kline D, Alkjaersig N. Assay methods and standard preparations of plasmin, plasminogen and urokinase in purified systems. Thromb Diath Haem 1969; 21: 259-72.
32. Tuliani VV, O'Rear EA. Circulatory concentrations of fibrinolytic species during thrombolytic therapy estimated by stirred-tank reactor analysis. Pharm Res 1997; 14: 1051-7.
33. The GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-82.
34. Hemker HC, Willems GM, Beguin S. A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemost 1986; 56: 9-17.
35. Hockin MF, Jones KC, Everse SJ, Mann KG. A model for the stoichiometric regulation of blood coagulation. J Biol Chem 2002; 277: 18322-33.